SynthesisMedicine2017

Overall survival of patients with KRAS wild-type tumor treated with FOLFOX/FORFIRI±cetuximab as the first-line treatment for metastatic colorectal cancer: A meta-analysis.

Ya-Fan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.